Ekso Bionics (EKSO) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Ekso Bionics Revenue Highlights


Latest Revenue (Y)

$18.28M

Latest Revenue (Q)

$4.13M

Main Segment (Y)

Product

Main Geography (Y)

INDONESIA

Ekso Bionics Revenue by Period


Ekso Bionics Revenue by Year

DateRevenueChange
2023-12-31$18.28M41.57%
2022-12-31$12.91M14.81%
2021-12-31$11.25M26.62%
2020-12-31$8.88M-36.18%
2019-12-31$13.92M22.81%
2018-12-31$11.33M54.11%
2017-12-31$7.35M-48.29%
2016-12-31$14.22M64.20%
2015-12-31$8.66M62.59%
2014-12-31$5.33M100.00%
2013-03-31-100.00%
2012-12-31--

Ekso Bionics generated $18.28M in revenue during NA 2023, up 41.57% compared to the previous quarter, and up 161.30% compared to the same period a year ago.

Ekso Bionics Revenue by Quarter

DateRevenueChange
2024-09-30$4.13M-16.59%
2024-06-30$4.95M31.79%
2024-03-31$3.76M-22.51%
2023-12-31$4.85M5.21%
2023-09-30$4.61M-2.04%
2023-06-30$4.70M14.10%
2023-03-31$4.12M16.08%
2022-12-31$3.55M6.67%
2022-09-30$3.33M-3.92%
2022-06-30$3.46M34.98%
2022-03-31$2.57M-37.02%
2021-12-31$4.08M33.68%
2021-09-30$3.05M37.90%
2021-06-30$2.21M15.76%
2021-03-31$1.91M-15.26%
2020-12-31$2.25M-22.20%
2020-09-30$2.90M27.96%
2020-06-30$2.26M54.22%
2020-03-31$1.47M-60.53%
2019-12-31$3.72M12.05%
2019-09-30$3.32M1.75%
2019-06-30$3.26M-9.79%
2019-03-31$3.62M9.71%
2018-12-31$3.30M29.25%
2018-09-30$2.55M-14.05%
2018-06-30$2.97M17.83%
2018-03-31$2.52M2.65%
2017-12-31$2.45M53.60%
2017-09-30$1.60M-14.46%
2017-06-30$1.87M30.01%
2017-03-31$1.44M-44.49%
2016-12-31$2.59M62.09%
2016-09-30$1.60M2.84%
2016-06-30$1.55M-81.71%
2016-03-31$8.49M336.75%
2015-12-31$1.94M-33.34%
2015-09-30$2.92M37.89%
2015-06-30$2.11M25.16%
2015-03-31$1.69M14.12%
2014-12-31$1.48M-6.81%
2014-09-30$1.59M32.67%
2014-06-30$1.20M12.75%
2014-03-31$1.06M100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30--

Ekso Bionics generated $4.13M in revenue during Q3 2024, up -16.59% compared to the previous quarter, and up 87.80% compared to the same period a year ago.

Ekso Bionics Revenue Breakdown


Ekso Bionics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Product$14.13M$10.79M---
Product and Service, Other$359.00K$493.00K---
Service$2.82M$2.56M---
Subscription$967.00K----
EksoHealth-$11.83M$9.75M$8.07M-
EksoWorks-$1.08M$1.50M$816.00K-
Collaborative Arrangements----$74.00K

Ekso Bionics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (77.31%), Service (15.43%), Subscription (5.29%), and Product and Service, Other (1.96%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Product$3.12M$3.81M$2.75M$10.55M$561.00K$2.81M$2.66M$2.52M------------
Product and Service, Other$195.00K$153.00K$94.00K$303.00K$177.00K$241.00K$72.00K$60.00K------------
Subscription$123.00K$146.00K$144.00K$722.00K----------------
Service$691.00K$836.00K$765.00K$2.10M$663.00K$619.00K$567.00K$671.00K------------
EksoWorks----$125.00K$54.00K$105.00K$237.00K$632.00K$333.00K$349.00K$183.00K$203.00K$158.00K$178.00K-----
EksoHealth----$4.00M$3.50M$3.22M$3.23M$3.44M$2.72M$1.86M$1.73M$2.05M$2.74M$2.09M-----
Royalty--------$280.00K-----------
Collaborative Arrangements----------------$67.00K$48.00K$18.00K$8.00K

Ekso Bionics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (75.56%), Service (16.74%), Product and Service, Other (4.72%), and Subscription (2.98%).

Ekso Bionics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 20Dec 19Dec 18
INDONESIA$18.28M----
POLAND$1.41M----
Americas-$6.81M---
Americas, Other-$252.00K---
Asia Pacific-$2.25M---
UNITED STATES-$6.56M$5.95M$9.07M$7.03M
EMEA-$3.85M---
EMEA, Other-$2.85M---
GERMANY-$1.00M---
Non-US--$2.94M$4.85M$4.30M

Ekso Bionics's latest annual revenue breakdown by geography, as of Dec 23: INDONESIA (92.86%), and POLAND (7.14%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
EMEA Other$537.00K$338.00K$360.00K$104.00K----------------
UNITED STATES$1.88M$2.59M$2.30M$3.68M$2.96M$1.67M$1.48M$2.07M$1.34M$1.78M$1.15M$1.04M$1.13M$1.93M$1.64M$1.25M$2.40M$1.94M$2.36M-
POLAND$113.00K$57.00K$626.00K$284.00K----------------
HONG KONG$214.00K$108.00K$118.00K-----------------
FRANCE$1.07M$522.00K$346.00K-----------------
EMEA$1.72M$1.52M$830.00K$863.00K$756.00K$1.44M$1.06M$786.00K$564.00K$828.00K$939.00K---------
Asia Pacific$517.00K$515.00K$597.00K$150.00K$404.00K$439.00K$723.00K$488.00K$605.00K$419.00K$74.00K---------
Americas$1.90M$2.92M$2.33M$3.69M$2.96M$1.67M$1.55M$2.19M$1.40M$1.80M$1.20M---------
Americas Other$18.00K-$32.00K$6.00K----------------
APAC Other$303.00K$106.00K$261.00K$32.00K----------------
MEXICO--------------------
ROMANIA-$181.00K$475.00K$449.00K----------------
INDONESIA-$301.00K$336.00K$668.00K----------------
CANADA-$330.00K------------------
GERMANY-$418.00K$124.00K$244.00K$515.00K$237.00K$126.00K$124.00K$313.00K$95.00K----------
EMEA, Other-----$512.00K$1.38M$372.00K$267.00K$440.00K$515.00K$548.00K--------
APAC, Other-----$404.00K$55.00K$330.00K$277.00K-----------
Americas, Other-----$4.00K$3.00K$73.00K$121.00K$55.00K$25.00K$44.00K--------
JAPAN------$205.00K$280.00K------------
BELGIUM----------$296.00K---------
SINGAPORE---------$48.00K----------
Non-US------------$869.00K$1.12M$971.00K$624.00K$219.00K$1.32M$1.38M$905.00K

Ekso Bionics's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (22.95%), UNITED STATES (22.73%), EMEA (20.79%), FRANCE (12.92%), EMEA Other (6.50%), Asia Pacific (6.26%), APAC Other (3.67%), HONG KONG (2.59%), POLAND (1.37%), and Americas Other (0.22%).

Ekso Bionics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LMATLeMaitre Vascular$193.48M$54.82M
AKYAAkoya Biosciences$96.63M$18.81M
PDEXPro-Dex$53.84M$14.89M
UTMDUtah Medical Products$50.22M$10.01M
EKSOEkso Bionics$18.28M$4.13M
NEPHNephros$14.24M$3.25M
GMVDG Medical Innovations$4.42M$-128.35K
FEMYFemasys$1.45M$221.48K
GCTKGlucoTrack--
POCIPrecision Optics-$4.20M
ATRIAtrion-$48.77M

EKSO Revenue FAQ


What is Ekso Bionics’s yearly revenue?

Ekso Bionics's yearly revenue for 2023 was $18.28M, representing an increase of 41.57% compared to 2022. The company's yearly revenue for 2022 was $12.91M, representing an increase of 14.81% compared to 2021. EKSO's yearly revenue for 2021 was $11.25M, representing an increase of 26.62% compared to 2020.

What is Ekso Bionics’s quarterly revenue?

Ekso Bionics's quarterly revenue for Q3 2024 was $4.13M, a -16.59% decrease from the previous quarter (Q2 2024), and a -10.38% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $4.95M, a 31.79% increase from the previous quarter (Q1 2024), and a 5.25% increase year-over-year (Q2 2023). EKSO's quarterly revenue for Q1 2024 was $3.76M, a -22.51% decrease from the previous quarter (Q4 2023), and a -8.88% decrease year-over-year (Q1 2023).

What is Ekso Bionics’s revenue growth rate?

Ekso Bionics's revenue growth rate for the last 3 years (2021-2023) was 62.54%, and for the last 5 years (2019-2023) was 31.34%.

What are Ekso Bionics’s revenue streams?

Ekso Bionics's revenue streams in c 23 are Product, Product and Service, Other, Service, and Subscription. Product generated $14.13M in revenue, accounting 77.31% of the company's total revenue, up 30.97% year-over-year. Product and Service, Other generated $359K in revenue, accounting 1.96% of the company's total revenue, down -27.18% year-over-year. Service generated $2.82M in revenue, accounting 15.43% of the company's total revenue, up 10.20% year-over-year. Subscription generated $967K in revenue, accounting 5.29% of the company's total revenue

What is Ekso Bionics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Ekso Bionics was Product. This segment made a revenue of $14.13M, representing 77.31% of the company's total revenue.